Literature DB >> 31492752

Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex.

Yuji Masuda1,2, Yasushi Saeki3, Naoko Arai3, Hidehiko Kawai4, Iwao Kukimoto5, Keiji Tanaka3, Chikahide Masutani6,2.   

Abstract

The human papillomavirus (HPV) oncoprotein E6 specifically binds to E6AP (E6-associated protein), a HECT (homologous to the E6AP C terminus)-type ubiquitin ligase, and directs its ligase activity toward the tumor suppressor p53. To examine the biochemical reaction in vitro, we established an efficient reconstitution system for the polyubiquitination of p53 by the E6AP-E6 complex. We demonstrate that E6AP-E6 formed a stable ternary complex with p53, which underwent extensive polyubiquitination when the isolated ternary complex was incubated with E1, E2, and ubiquitin. Mass spectrometry and biochemical analysis of the reaction products identified lysine residues as p53 ubiquitination sites. A p53 mutant with arginine substitutions of its 18 lysine residues was not ubiquitinated. Analysis of additional p53 mutants retaining only one or two intact ubiquitination sites revealed that chain elongation at each of these sites was limited to 5-6-mers. We also determined the size distribution of ubiquitin chains released by en bloc cleavage from polyubiquitinated p53 to be 2-6-mers. Taken together, these results strongly suggest that p53 is multipolyubiquitinated with short chains by E6AP-E6. In addition, analysis of growing chains provided strong evidence for step-by-step chain elongation. Thus, we hypothesize that p53 is polyubiquitinated in a stepwise manner through the back-and-forth movement of the C-lobe, and the permissive distance for the movement of the C-lobe restricts the length of the chains in the E6AP-E6-p53 ternary complex. Finally, we show that multipolyubiquitination at different sites provides a signal for proteasomal degradation.
© 2019 Masuda et al.

Entities:  

Keywords:  E3 ubiquitin ligase; E6-associated protein; Lys48-linked ubiquitin chain; enzyme mechanism; human papillomavirus (HPV) oncoprotein E6; in vitro reconstitution; linkage specificity; mass spectrometry (MS); p53; polyubiquitin chain

Mesh:

Substances:

Year:  2019        PMID: 31492752      PMCID: PMC6791319          DOI: 10.1074/jbc.RA119.008374

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination.

Authors:  Peter S Brzovic; Alexei Lissounov; Devin E Christensen; David W Hoyt; Rachel E Klevit
Journal:  Mol Cell       Date:  2006-03-17       Impact factor: 17.970

2.  Polyubiquitination by HECT E3s and the determinants of chain type specificity.

Authors:  Hyung Cheol Kim; Jon M Huibregtse
Journal:  Mol Cell Biol       Date:  2009-04-13       Impact factor: 4.272

3.  The parallel reaction monitoring method contributes to a highly sensitive polyubiquitin chain quantification.

Authors:  Hikaru Tsuchiya; Keiji Tanaka; Yasushi Saeki
Journal:  Biochem Biophys Res Commun       Date:  2013-05-31       Impact factor: 3.575

4.  Physical interaction between specific E2 and Hect E3 enzymes determines functional cooperativity.

Authors:  S Kumar; W H Kao; P M Howley
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

5.  E6AP/UBE3A ubiquitin ligase harbors two E2~ubiquitin binding sites.

Authors:  Virginia P Ronchi; Jennifer M Klein; Arthur L Haas
Journal:  J Biol Chem       Date:  2013-02-25       Impact factor: 5.157

6.  Occurrence of a polyubiquitin structure in ubiquitin-protein conjugates.

Authors:  A Hershko; H Heller
Journal:  Biochem Biophys Res Commun       Date:  1985-05-16       Impact factor: 3.575

7.  Complete reconstitution of conjugation and subsequent degradation of the tumor suppressor protein p53 by purified components of the ubiquitin proteolytic system.

Authors:  D Shkedy; H Gonen; B Bercovich; A Ciechanover
Journal:  FEBS Lett       Date:  1994-07-11       Impact factor: 4.124

8.  Conformational flexibility underlies ubiquitin ligation mediated by the WWP1 HECT domain E3 ligase.

Authors:  Mark A Verdecia; Claudio A P Joazeiro; Nicholas J Wells; Jean-Luc Ferrer; Marianne E Bowman; Tony Hunter; Joseph P Noel
Journal:  Mol Cell       Date:  2003-01       Impact factor: 17.970

9.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.

Authors:  M Scheffner; J M Huibregtse; R D Vierstra; P M Howley
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

10.  Dynamics of human replication factors in the elongation phase of DNA replication.

Authors:  Yuji Masuda; Miki Suzuki; Jinlian Piao; Yongqing Gu; Toshiki Tsurimoto; Kenji Kamiya
Journal:  Nucleic Acids Res       Date:  2007-10-11       Impact factor: 16.971

View more
  2 in total

1.  HPV E7 inhibits cell pyroptosis by promoting TRIM21-mediated degradation and ubiquitination of the IFI16 inflammasome.

Authors:  Yinjing Song; Xia Wu; Yaohan Xu; Jiang Zhu; Jiaying Li; Ziqi Zou; Luxia Chen; Boya Zhang; Chunting Hua; Han Rui; Qiaoli Zheng; Qiang Zhou; Qingqing Wang; Hao Cheng
Journal:  Int J Biol Sci       Date:  2020-09-13       Impact factor: 6.580

Review 2.  Exploring the Roles of HERC2 and the NEDD4L HECT E3 Ubiquitin Ligase Subfamily in p53 Signaling and the DNA Damage Response.

Authors:  Nicholas A Mathieu; Rafael H Levin; Donald E Spratt
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.